Taiwan Advanced Nanotech Inc.
Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plat… Read more
Taiwan Advanced Nanotech Inc. - Asset Resilience Ratio
Taiwan Advanced Nanotech Inc. (6797) has an Asset Resilience Ratio of 37.65% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Taiwan Advanced Nanotech Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Taiwan Advanced Nanotech Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$504.13 Million | 37.65% |
| Total Liquid Assets | NT$504.13 Million | 37.65% |
Asset Resilience Insights
- Very High Liquidity: Taiwan Advanced Nanotech Inc. maintains exceptional liquid asset reserves at 37.65% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Taiwan Advanced Nanotech Inc. Industry Peers by Asset Resilience Ratio
Compare Taiwan Advanced Nanotech Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FluroTech Ltd
OTCQB:FLURF |
Medical Devices | 0.00% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Taiwan Advanced Nanotech Inc. (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Taiwan Advanced Nanotech Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 28.22% | NT$388.27 Million | NT$1.38 Billion | +0.71pp |
| 2023-12-31 | 27.50% | NT$492.57 Million | NT$1.79 Billion | +4.22pp |
| 2022-12-31 | 23.28% | NT$542.60 Million | NT$2.33 Billion | -9.88pp |
| 2021-12-31 | 33.16% | NT$729.26 Million | NT$2.20 Billion | +25.06pp |
| 2020-12-31 | 8.11% | NT$152.63 Million | NT$1.88 Billion | -- |